Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
LONDON, Dec 17 (Reuters) - GlaxoSmithKline said on Tuesday it would stop paying doctors to promote its products through speaking engagements and end linking compensation for its sales representatives to the number of prescriptions doctors write. It also plans to stop payments to healthcare
17 Dec 13 07:19Dec 16 (Reuters) - GlaxoSmithKline Plc will stop paying doctors to promote its products, Chief Executive Andrew Witty said in an interview with the New York Times, in a move that could be a first for a major drug company. GSK will also stop tying compensation of sales representatives to the
17 Dec 13 02:13* BSE index falls 0.27 pct; NSE ends 0.22 pct lower * India's wholesale price inflation hits 14-month high * GlaxoSmithKline Pharma surges on open offer by parent * Overseas investors snap 10-day buying streak in Indian shares By Abhishek Vishnoi MUMBAI, Dec 16 (Reuters) - In
16 Dec 13 11:14* To raise stake in pharma unit to up to 75 pct from 50.7 pct * Tender offer price set at 3,100 rupees, a premium of 26 pct * Raised stake in consumer healthcare unit in Feb for $900 mln * Executive sees volume growth opportunity in India By Sumeet Chatterjee MUMBAI,
16 Dec 13 07:04Drug maker GlaxoSmithkline plans to increase its control over its publicly listed pharmaceutical subsidiary in India. GSK is launching a voluntary open offer in February to lift its stake in GlaxoSmithKline Pharmaceuticals Limited from 50.7% to up to 75% at a price of 3,100 Indian rupees per share.
16 Dec 13 07:02* India's benchmark BSE index gains 0.15 percent, while the broader NSE index is up 0.12 percent. * Lenders gain on value buying after four days of falls. IDFC Ltd gains 1.6 percent after falling more than 10 percent in four sessions, while ICICI Bank Ltd is up 1.2 percent. * GlaxoSmithKline Pha
16 Dec 13 04:26MUMBAI, Dec 16 (Reuters) - Shares in India's GlaxoSmithKline Pharmaceuticals Ltd surged 20 percent in pre-open trading to its maximum daily limit after GlaxoSmithKline Plc (GSK) said on Monday it plans to buy up to 20.6 million shares to raise its stake in its Indian unit. GSK is offering t
16 Dec 13 03:40MUMBAI, Dec 16 (Reuters) - GlaxoSmithKline Plc (GSK) said on Monday it plans to raise its stake in its Indian pharmaceutical unit to up to 75 percent from 50.7 percent through an open offer in a deal worth about 629 million pounds ($1.02 billion). With the latest India deal, GSK is set to
16 Dec 13 03:37MUMBAI, Dec 16 (Reuters) - GlaxoSmithKline Plc (GSK) said on Monday it plans to raise its stake in its Indian pharmaceutical unit to up to 75 percent from 50.7 percent, through an open offer, in a deal worth about 629 million pounds ($1.02 billion). GSK will buy up to 20.6 million shares o
16 Dec 13 03:09By Megha Rajagopalan BEIJING, Dec 13 (Reuters) - A China state television investigative report accusing Starbucks of overcharging local customers for coffee triggered enormous disquiet among journalists at the network and even some soul-searching after it aired. The October segment -
12 Dec 13 21:01LONDON, Dec 11 (Reuters) - GlaxoSmithKline is to invest another 200 million pounds ($330 million) on advanced manufacturing in Britain, the company said on Wednesday, underlining the draw of a tax break designed to encourage research and development. Britain's so-called "patent box" scheme,
11 Dec 13 00:01Dec 6 (Reuters) - GlaxoSmithKline and Theravance Inc said on Friday that their combination therapy met the main goal of improving lung function in asthma patients in a late-stage trial. The therapy consists of the corticosteroid, fluticasone furoate, which reduces inflammation, and a long-
6 Dec 13 13:58* U.S. firms seeking to block release of drug data by EMA * AbbVie, InterMune say they defending business secrets * EU's top court refers case back to lower court By Ben Hirschler LONDON, Dec 5 (Reuters) - A legal case over access to details of clinical trials held by Euro
5 Dec 13 15:48By Ransdell Pierson Dec 5 (Reuters) - Eli Lilly and Co said on Thursday it would not seek approval for edivoxetine, its experimental drug to treat major depression, after it failed to meet its primary goal in three late-stage trials. Edivoxetine, a member of a family of medicines call
5 Dec 13 14:37By Bill Berkrot NEW YORK, Dec 4 (Reuters) - Global drugmaker Pfizer Inc will broaden access to information from its scores of clinical trials to independent researchers and to patients who take part in the studies, the company said on Wednesday. Pfizer, the largest U.S. pharmaceutica
4 Dec 13 21:04
Last checked at